|
|
 |
|
 |
|
Robert J. Dow, MBChb
Chief Medical Officer
Dr. Dow joined Cell Genesys in March 2005 and serves as senior vice
president of medical affairs. He currently oversees market, label
expansion and post-marketing development activities associated with
Cell Genesys' product portfolio. Prior to Cell Genesys, he was chief
executive officer of Biolitec Pharma Ltd., a U.K.-based biotechnology
company, and also previously held senior executive positions with
Quantanova and Scotia Holdings, plc. Prior to that, Dr. Dow was head
of Global Drug Development with Hoffman-La Roche in Basel, Switzerland
and previously was with Syntex Corporation for over 10 years in various
senior positions in drug development. Dr. Dow holds a B.Sc. in Medical
Science from the University of St. Andrews and his medical qualification,
an MBChB degree, from the University of Dundee in Scotland. He also
is a Fellow of the Royal College of Physicians of Edinburgh. |
|
|
|
